Pay in 4 interest-free payments of $50.00 Learn more
Ships within 48 hours · Estimated delivery Jul 25 - Jul 30
moderately in the middle and late stages of some cancers
CD5 serves to mitigate activating signals from the BCR so that the B-1 cells can only be activated by very strong stimuli (such as bacterial proteins) and not by normal tissue proteins
(2002) Biochemistry 41:2543
in accordance with the general steps to make frozen section and paraffin section
CD25/IL-2Rα, FOXP3, CD4 Antibody Panel Size:100μl moderately in the middle andProduct Specification Antibody Type Recombinant mAb Application mIHC Reactivity Hu Conjugation Unconjugated Physical Appearance Liquid Storage Buffer PBS, 40% Glycerol, 0. 05% BSA, 0. 03% Proclin 300 Stability & Storage 12 months from date of receipt reconstitution, 20 C as supplied Dilution application dilution species mIHC 1: 200 Background CD25 IL 2R, FOXP3, CD4 Antibody Panel contains 3 recombinant monoclonal antibodies against CD25 IL 2R, FOXP3,